NASDAQ · Medical - Devices

RPID (RPID) Stock

$2.01 +1.01% NASDAQ: RPID Healthcare

Valuation

MetricValue
Price$2.01
Market Cap$91.10M
P/E Ratio-1.91
P/B Ratio2.79
P/S Ratio2.68
EPS (TTM)$-1.05
52-Week High$4.94
52-Week Low$1.66
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-142.42%
ROA-62.67%
ROCE-142.42%
Gross Margin-138.24%
Operating Margin-138.24%
Net Margin-1.46%
Debt/Equity1.16
Current Ratio3.39

Annual Financials (USD)

Metric20212022202320242025
Revenue$23.0M$17.0M$23.0M$28.0M$34.0M
Operating Profit$-47.0M$-63.0M$-57.0M$-50.0M$-47.0M
Net Profit$-74.0M$-61.0M$-52.0M$-47.0M$-47.0M
EPS$-1.88$-1.43$-1.22$-1.08$-1.05
Op Margin-203.3%-369.0%-251.2%-178.0%-141.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$241.0M$191.0M$143.0M$98.0M$75.0M
Total Liabilities$20.0M$26.0M$25.0M$23.0M$42.0M
Cash$178.0M$27.0M$24.0M$17.0M$20.0M
Borrowings$0$8.0M$7.0M$6.0M$24.0M

Latest News

Rapid Micro Biosystems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jun 10, 2026 Rapid Micro Biosystems Announces Pricing of Up to Approximately $32 Million Underwritten Offering GlobeNewswire · May 19, 2026 Rapid Micro Biosystems Inc (RPID) Q1 2026 Earnings Call Highlights: Strong Revenue Growth ... GuruFocus.com · May 14, 2026 Rapid Micro Biosystems Q1 Earnings Call Highlights MarketBeat · May 14, 2026 Rapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue Estimates Zacks · May 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-55.0M$-59.0M$-45.0M$-44.0M$-31.0M
Investing Cash Flow$-17.0M$-100.0M$40.0M$35.0M$13.0M
Financing Cash Flow$-1.0M$1.0M$0$0$0
Net Cash Flow$148.0M$-151.0M$-3.0M$-7.0M$3.0M
Free Cash Flow$-58.0M$-65.0M$-47.0M$-46.0M$-32.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-40.33%
Quick Ratio1.66
Interest Coverage-47.00
Return 1Y-35.58%
Return 3Y116.51%
Return 5Y-91.29%

Ownership

Insiders Held10.26%
Institutions Held43.15%
Institutions Float Held48.08%
Institutional HolderSharesReport Date
Bain Capital Life Sciences Investors, LLC8,434,5602026-03-31
ABG-WTT Global Life Science Capital Partners GP Ltd1,848,2962026-03-31
Vanguard Capital Management LLC982,4942026-03-31
Essex Investment Management Co LLC883,9312026-03-31
Advent International LP552,3772026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
APYX $4.07 -1.21% -17.90 $171.39M 0.00%
CGTX $0.89 +0.21% -3.94 $79.79M 0.00%
LNSR $5.25 -1.87% 6.53 $63.55M 0.00%
LUCD $0.97 +1.47% -1.45 $98.94M 0.00%
NSPR $0.69 +0.87% -1.21 $32.30M 0.00%

About RPID

RPID is led by CEO Robert G. Spignesi Jr., employs 163 people, headquartered in US, publicly traded since 2021.

RPID stock trades at $2.01 with a market capitalization of $91.10M. The stock is valued at a price-to-earnings (P/E) ratio of -1.91, price-to-book of 2.79, price-to-sales of 2.68. Over the past 52 weeks the stock has ranged between $1.66 and $4.94, and currently trades 59.3% below its 52-week high.

On profitability, RPID generates a return on equity (ROE) of -142.42%, return on capital employed of -142.42%, an operating margin of -138.24%, a net profit margin of -1.46%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides